Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Dr Aminah Jatoi is Professor of Oncology at the Mayo Clinic in Rochester, Minnesota, USA. A practicing medical oncologist, she has been interested in symptom control research in cancer patients for over 20 years. She holds a special interest in cancer-associated weight loss, having completed a three-year fellowship in clinical nutrition. She is the author of more than 300 publications. Dr Jatoi has received research funding from multiple sources, including the United States’ National Cancer Institute.
Barry J.A. Laird
Barry J.A. Laird graduated in medicine from the University of Glasgow, UK, in 1997 and completed higher specialist training in palliative medicine in 2009. During his training in palliative medicine he was awarded a National Cancer Research Institute Fellowship and joined the academic palliative medicine department at the University of Edinburgh, UK, with Professor Marie Fallon. He completed his MD in cancer induced bone pain and neuropathic cancer pain in 2009 and was then awarded a fellowship from the European Palliative Care Research Centre (PRC) working with Professor Stein Kaasa. His interest in cachexia was nurtured by the late Professor Kenneth Fearon.
He currently holds positions as a Senior Lecturer in Palliative Medicine at the University of Edinburgh and a consultant in palliative medicine in St Columba's Hospice, UK.
His research interests are focussed around symptoms in life-limiting illness and the role of palliative care in optimising the care of malignant (lung and pancreatic cancer) and non-malignant disease. He leads a research programme examining the systemic inflammatory response in cachexia, symptom genesis and prognosis in cancer. He has published over 70 papers and is the CI and PI of clinical trials in symptomatology and treatment.
Gustavo De Simone
Gustavo De Simone was born in Argentina in 1955 and graduated as a physician in 1979, completing his specialty in medical oncology. He was appointed Medical Director of the Palliative Care Program at Mainetti Comprehensive Cancer Centre in La Plata, Argentina, in 1991. Since then he has contributed to the development of specialist palliative care services in Buenos Aires and other cities in Argentina. He has led development of palliative care education mainly at postgraduate level within the University of La Plata, Argentina, from 1992 to 1997 and Universidad del Salvador, Argentina, from 1998 to present, and has been involved in the development of the research and development programs. He is Medical Director of Pallium Latinoamerica Study Centre (NGO), which has had academic links with Oxford International Centre for Palliative Care since 1993.
In June 2005, Dr De Simone was made Coordinator of Postgraduate Training in Palliative Care (Residence Program) within the Ministry of Health, Buenos Aires Government. He is currently Chief of Education and Research Department at the Bonorino Udaondo Public Hospital in Buenos Aires, Argentina.
In 1998 he became Honorary Professor of Palliative Medicine at the Universidad del Salvador, Buenos Aires, and Director of the Career of Medical Oncology. This is the first Chair in Palliative Medicine in Argentina and provides a focal point for educational developments in South America. Based on his commitments to education, he received the 2003 International Association for Hospice and Palliative Care (IAHPC) Annual Vittorio Ventafridda Award.
In 2009 he was made Director of the working group on End of Life Decisions at the Medical Ethics Committee of the National Academy of Medicine, and from 2008 to 2011 he was Argentina's country leader for the EU project ‘OPCARE9’.
Since 2011 he has been the Director of MSc in Palliative Care at the Universidad del Salvador and has been re-elected President of the Argentinean Association for Palliative Care from 2012 to 2014.
Professor Bridget Johnston holds the post of Florence Nightingale Foundation Chair in Clinical Nursing in the School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, UK. This a joint post between the University of Glasgow and NHS Greater Glasgow and Clyde in Scotland, UK. Bridget is a registered nurse and has a clinical, educational and research background in palliative care. She graduated with her PhD from the University of Glasgow in 2002. Bridget was a Professor of Palliative and Supportive Care and co-lead of the Sue Ryder Care Centre for the Study of Supportive, Palliative and End of Life Care at University of Nottingham, UK, from 2013–2016. Bridget's research has centred on self-care and advanced cancer, telehealth and palliative care symptom management in palliative care and laterally developing and testing interventions related to dignity and end of life care. Bridget supports a number of PhD students from across the world doing palliative care studies. Bridget was appointed as a Patron of Macmillan Cancer Support Alumni in 2015. Bridget is chair of the Scottish palliative care research forum. Bridget is Section editor for BMC Nursing and Section Editor (end of life care) for Current Opinion in Supportive and Palliative Care. Bridget tweets as @BridgetJohnst and co-hosts a palliative/end of life twitter group @Weeolc.
Dr Dalley is a Consultant Haematologist at Southampton General, UK. He has specialty interest in the myelodysplastic syndromes, acute myeloid leukaemia, bone marrow transplantation as well as the diagnosis of haematological cancers.
Having graduated from St Thomas's Hospital Medical School, University of London, UK, he underwent postgraduate training in haematology at St Bartholomew's Hospital, UK. Whilst there, he developed a research interest in the cytogenetics of acute myeloid leukaemia, and the clinical management of AML in older adult patients. After completing his specialist training in haematology, he worked at Vancouver General Hospital, Canada, as a British Columbia Cancer Agency Leukaemia and Bone Marrow Transplant Fellow. Having completed his fellowship, he returned to the United Kingdom and has been a substantive consultant haematologist for fourteen years.
He developed ambulatory care programmes for patients with haematological cancer, developed and led a specialised integrated haematological malignancy diagnostic service at Sheffield Teaching Hospitals NHS Foundation Trust, UK, where he worked for seven years as a Consultant Haematologist. He has co-written national clinical guidelines for the management of the myelodysplastic syndromes and the National Institute for Clinical Excellence (NICE) Improving Outcomes Guidance for Haematological Malignancy. Dr Dalley is currently a member of the National External Quality Assurance Scheme (NEQAS) Leukaemia Immunophenotyping Executive Committee, NEQAS Molecular Scientific Advisory Group and the UK MDS Executive Committee. He is also a Joint Accreditation Committee ISCT-Europe (JACIE) Clinical Inspector for BMT programmes.
His current clinical practice is focused on the management of aggressive myeloid malignancies. His department is recognised as a Center of Excellence by The MDS Foundation.